Trial reportScientific reports2023
Safety and feasibility of reduced-port robotic distal gastrectomy for gastric cancer: a phase I/II clinical trial using the da Vinci Single Port(SP) robotic system.
Trial report in Scientific reports, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 20 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
The Safety and Feasibility of Reduced Port Robotic Distal Gastrectomy Using da Vinci SP for Early Gastric Cancer
Efficacy and Safety Assessment of Single-port Robotic Radical Gastrectomy for Gastric Cancer: a Phase 2a Trial Based on the IDEAL Framework
Who cites it
20 citing papers in PubMed, 1 synthesis or guideline pooled it, 23 citations in OpenAlex.
- Application of the Da Vinci Single-Port (SP) Robot in General Surgery: A First Systematic Review.The international journal of medical robotics + computer assisted surgery : MRCAS · 2025Pooled it
- Efficacy and Safety Analysis of Single-Port Robotic Assisted Cholecystectomy Using a Novel Surgical Platform: A Bicentre, Single-Arm, Prospective Phase II Clinical Study.The international journal of medical robotics + computer assisted surgery : MRCAS · 2026Trial
- Three-year follow-up outcomes of postoperative quality of life from a randomized controlled trial comparing multi-port versus single-port laparoscopic distal gastrectomy.Surgical endoscopy · 2025Trial
- Surgical team configuration, technical errors, and workload in robotic distal gastrectomy.Surgical endoscopy · 2026Article
- Feasibility and perioperative safety of robotic liver resection using the da Vinci SP system: early single-center case series.Surgical endoscopy · 2026Article
- Cooperative integrated surgical robots for high-performance targeted therapies.Innovation (Cambridge (Mass.)) · 2026Review
- Comparison of textbook outcomes and postoperative pain trajectories between reduced-port and conventional robotic distal gastrectomy: a cumulative sum (CUSUM)-adjusted propensity score-matched analysis.Journal of robotic surgery · 2026Article
- New access to intraluminal gastric pathologies: the SP da Vinci transgastric approach.Surgical endoscopy · 2026Article
- A comparative analysis of surgical outcomes after robotic gastrectomy with conventional multiport, single-site, and single-port surgical system for gastric cancer.Annals of surgical treatment and research · 2026Article
- Article
- Simultaneous Resection of Rectal and Gastric Cancer with the da Vinci Single-Port System: A Case Report.Journal of the anus, rectum and colon · 2026Article
- Single-port robotic gastrectomy in gastric cancer: a narrative review on the state of the art and outlook.Annals of surgical treatment and research · 2026Review
- Safety and feasibility of novel single-port robotic systems in colorectal cancer surgery: a comparative study with the da Vinci Xi system.International journal of colorectal disease · 2025Article
- The da Vinci Single-Port Robotic Platform in General Surgery: A Scoping Review of Current Applications and Outcomes.Journal of clinical medicine · 2025Review
- Safety and efficacy of the Toumai robotic assisted versus the DaVinci robotic assisted radical gastrectomy for patients with gastric cancer.BMC surgery · 2025Article
- Outcomes of Reduced-Port Robotic Gastrectomy Compared With the Conventional Laparoscopy in Korea (KLASS-13).Journal of gastric cancer · 2025Article
- Initial clinical experiences of robotic distal gastrectomy for gastric cancer using the Da Vinci™ SP system: a single-center retrospective study.Langenbeck's archives of surgery · 2025Article
- Single-Port Robotic Posterior Retroperitoneoscopic Adrenalectomy: Current Perspectives, Technical Considerations, and Future Directions.Journal of clinical medicine · 2025Review
- Short-term outcomes of da Vinci SP versus Xi for rectal cancer surgery: a propensity score matching analysis of two tertiary center cohorts.Surgical endoscopy · 2025Article
- Current Issues in Reduced-Port Gastrectomy: A Comprehensive Review.Journal of gastric cancer · 2024Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Minimally invasive surgery reduces surgical trauma and the size and number of incisions. The da Vinci SP robotic surgical system was designed to overcome the technical demands of single-incision laparoscopic surgery. This study aimed to demonstrate the safety and feasibility of single-port (SP) robotic distal gastrectomy (SPRDG) for patients with gastric cancer using the da Vinci SP system (Intuitive Surgical Inc., Sunnyvale, CA, USA). This study was designed as a single-arm prospective phase I/II clinical trial of SPRDG (first posted date: 21/09/2021, NCT05051670; clinicaltrials.gov). SPRDG using the da Vinci SP system was performed on 19 patients with gastric cancer between December 2021 and October 2022. The primary outcome was the safety of SPRDG as measured by major postoperative complications. The secondary outcomes were operation time, bleeding amount, bowel motility recovery, and length of hospital stay. SPRDG was performed in all 19 patients without unexpected events, such as use of additional trocars or conversion to laparoscopic or open surgery. No major complications occurred postoperatively (0/19, 0.0%). The mean operation time was 218 min (range 164-286 min). The mean hospital stay duration was 3.2 days (range 2-4 days). This phase I/II clinical trial, performed by a single expert surgeon, demonstrated the safety and feasibility of SPRDG with the da Vinci SP system in selected patients with gastric cancer. SPRDG could be a reasonable alternative to conventional or reduced-port minimally invasive gastrectomy, as it has cosmetic advantages, early recovery, and safe discharge.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.